Coldstream Capital Management Inc. Sells 7,019 Shares of UnitedHealth Group Incorporated $UNH

Coldstream Capital Management Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 25.6% in the second quarter, Holdings Channel.com reports. The firm owned 20,428 shares of the healthcare conglomerate’s stock after selling 7,019 shares during the quarter. Coldstream Capital Management Inc.’s holdings in UnitedHealth Group were worth $6,373,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of UNH. Brighton Jones LLC increased its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its stake in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Ted Buchan & Co grew its stake in shares of UnitedHealth Group by 4.0% in the first quarter. Ted Buchan & Co now owns 5,900 shares of the healthcare conglomerate’s stock worth $3,090,000 after acquiring an additional 229 shares during the last quarter. Neo Ivy Capital Management bought a new position in UnitedHealth Group in the 1st quarter worth about $557,000. Finally, Mediolanum International Funds Ltd increased its stake in UnitedHealth Group by 1.7% during the 1st quarter. Mediolanum International Funds Ltd now owns 179,673 shares of the healthcare conglomerate’s stock valued at $92,718,000 after purchasing an additional 3,053 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $319.40 on Friday. The firm has a 50 day moving average of $344.69 and a 200 day moving average of $316.39. The firm has a market capitalization of $289.32 billion, a price-to-earnings ratio of 16.67, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same period in the prior year, the business posted $7.15 EPS. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several analyst reports. Piper Sandler reduced their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research report on Tuesday, October 28th. KeyCorp boosted their price target on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Barclays upped their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Finally, Sanford C. Bernstein increased their price objective on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Eighteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.